WuXi AppTec's Hong Kong-traded stock jumped 37% as major shareholders JPMorgan Chase, UBS Group, and BlackRock increased their stakes. The company is set to release its half-year earnings on August 3, with high market expectations.
NASA-backed research suggests plants could produce medicines for astronauts on long-duration missions to the Moon and Mars. A study used a tobacco relative and a harmless plant virus to create therapeutic proteins, aiming to reduce reliance on Earth-launched medical supplies and enhance self-sufficiency in deep space.
President Trump plans 100-200% tariffs on generic drugs by 2028 to reshore production, impacting Indian pharma. US and China are set for AI talks amid IP theft concerns. US strikes Iran for an 11th night as Secretary Rubio questions Iran's seriousness in peace talks. Alphabet and Tesla earnings are also due.
China's NMPA has approved a rare-disease therapy for commercial sales to treat narcolepsy type 1 in individuals aged 16 and older. The unnamed drug previously received fast-track status in the US and orphan-drug designation in Japan and the EU, indicating international recognition for its importance.
San Diego-based Axiom Biosciences plans a "contrarian" Hong Kong IPO in 2027, followed by a 2029 U.S. listing, to access sophisticated biotech investors and Asian partners. This move contrasts with the traditional trend of Chinese firms listing in the U.S., highlighting Hong Kong's growing appeal as a biotech fundraising hub despite U.S. market depth.
Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.
China's market approvals in the first half of the year were dominated by domestically produced novel drugs, accounting for over 80% of clearances. This includes CARsgen Therapeutics' Satri-cel, the world's first CAR-T treatment for solid tumors, and Neuracle Medical Technology's implantable brain-computer interface system.
South Korea's biopharmaceutical exports are projected to reach a record high in the first half of this year, with an estimated $4.5 billion in shipments, a 15.3% increase. The sector's growth is driven by recombinant protein drugs, with key export markets including Switzerland, the United States, and Hungary.
A midtown Manhattan building was evacuated Tuesday after structural steel beams began bending, prompting officials to establish a collapse zone. Tourists and locals scrambled for accommodation as nearby hotels and buildings were also evacuated as a precaution. No injuries were reported.
A midtown Manhattan building was evacuated Tuesday after structural issues caused steel beams to bend, leading to the creation of a "collapse zone." Tourists and locals were forced to find new accommodations as nearby hotels and buildings were also evacuated as a precaution. No injuries were reported, and emergency repairs have begun.
A midtown Manhattan building was evacuated Tuesday after steel beams began bending, prompting concerns of collapse. Tourists and locals were displaced as emergency repairs began, with officials assessing the unstable structure.
South Korea's biopharmaceutical exports reached a record $4.5 billion in the first half of 2024, a 15.3% increase year-on-year. This surge represents 86.5% of total pharmaceutical exports, with significant growth in US and European markets. Projections indicate a new annual record if the upward trend continues.
An under-construction high-rise near Grand Central Terminal in NYC was evacuated Tuesday due to fears of collapse. Structural beams buckled on the 21st and 22nd floors, with reports of falling bricks and sagging floors. No injuries were reported, and a "collapse zone" was established.
The US trade deficit ballooned by 42.2% in May to $77.6 billion, driven by a 3.3% rise in imports of goods like pharmaceuticals, mobile phones, and semiconductors, while exports fell 3.2%. This marks the largest monthly increase in a year, coinciding with AI spending and record petroleum imports.
A 38-story building under construction near Grand Central Terminal in NYC was evacuated Tuesday after bricks fell and structural issues, including buckling beams and sagging floors, were reported. No injuries occurred, but nearby buildings and a school were also evacuated.
Health groups and doctors urge Andy Burnham to scrap the UK-US trade deal on medicines, warning it prioritizes pharmaceutical profits over NHS patients and could lead to hundreds of thousands of avoidable deaths due to increased drug costs.
Russian Prime Minister Mikhail Mishustin stated that Russia sees potential for joint development of various vessels and underwater robotic systems with Indonesia. Other areas of interest include metallurgy, pharmaceuticals, medical equipment, and digital technologies.
A UK-US pharmaceutical trade deal may cause 229,000 excess deaths in the UK by 2036 due to diverted NHS funding, according to BMJ research, as billions are allocated to US medicines with no additional NHS funding
Chinese AI-driven drug-design firms are rapidly expanding their global presence through cross-border deals, with out-licensing agreements reaching US$75 billion in the first five months of 2026, despite increasing scrutiny from Washington on Chinese biotech companies. A deal between Metis TechBio and Boulevard Bio exemplifies this trend.
South Korea's pharmaceutical exports exceeded $10 billion in 2025, a 12.4% increase from the previous year. Production also hit a record high of 33.8 trillion won, driven by biopharmaceuticals and contract manufacturing capabilities.
Alibaba Group will pay $600 million to resolve a US Department of Justice investigation into allegations its platforms facilitated the sale of thousands of illegal pharmaceuticals and controlled substances into the US. The settlement involves non-prosecution agreements with Alibaba and AUS Merchant Services.
US pharmaceutical company Indivior will withdraw its "life-saving" opioid dependency drug Sublocade from the Australian market by December 31, citing commercial reasons. The decision has alarmed doctors and pharmacists, who note Sublocade's effectiveness and patient preference over alternatives like Buvidal. This follows AstraZeneca's recent withdrawal of Zoladex, also due to commercial viability concerns.
Royalty Pharma, the world's largest biopharmaceutical royalty buyer, established its first Asia-Pacific base in Hong Kong. This move aims to capitalize on record Chinese biotech out-licensing deals and offers an alternative financing method amidst US investment restrictions and geopolitical uncertainties.
The FDA has chosen seven companies, including Eli Lilly and Regeneron, for its PreCheck pilot program to speed up reviews of new domestic pharmaceutical manufacturing facilities. The initiative aims to cut review times by up to 14 months by allowing construction-phase inspections.
